Sincalide injection
Products billed under this code include Sincalide, Sincalide Inj.
Payment limit per 5 MCG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Sincalide, Sincalide Inj.
Payment limit per 5 MCG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Sincalide | FreseniUS Kabi USA, LLC | 63323-0579-05 | 10 | $1,456.38 |
| Sincalide | Fosun Pharma USA Inc. | 72266-0248-05 | 5 | $728.19 |
| Sincalide Inj | Bracco Diagnostics Inc. | 00270-0556-15 | 10 | $1,456.38 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $145.638 | +$35.176 | 5 MCG | Sincalide injection | v1, posted September 17, 2026 |
| 3Q26 | $110.462 | +$2.259 | 5 MCG | Sincalide injection | v1, posted September 15, 2026 |
| 2Q26 | $108.203 | −$1.926 | 5 MCG | Sincalide injection | v1, posted September 15, 2026 |
| 1Q26 | $110.129 | −$13.233 | 5 MCG | Sincalide injection | v1, posted September 15, 2026 |
| 4Q25 | $123.362 | −$12.611 | 5 MCG | Sincalide injection | v1, posted September 8, 2026 |
| 3Q25 | $135.973 | −$7.285 | 5 MCG | Sincalide injection | v1, posted March 10, 2026 |
| 2Q25 | $143.258 | +$28.871 | 5 MCG | Sincalide injection | v1, posted March 10, 2026 |
| 1Q25 | $114.387 | −$9.231 | 5 MCG | Sincalide injection | v1, posted December 19, 2025 |
| 4Q24 | $123.618 | −$18.902 | 5 MCG | Sincalide injection | v1, posted June 11, 2025 |
| 3Q24 | $142.52 | +$12.777 | 5 MCG | Sincalide injection | v1, posted June 11, 2025 |
| 2Q24 | $129.743 | −$3.356 | 5 MCG | Sincalide injection | v1, posted March 11, 2025 |
| 1Q24 | $133.099 | +$4.063 | 5 MCG | Sincalide injection | v1, posted December 19, 2024 |
| 4Q23 | $129.036 | −$4.507 | 5 MCG | Sincalide injection | v1, posted October 10, 2024 |
| 3Q23 | $133.543 | +$17.268 | 5 MCG | Sincalide injection | v1, posted June 5, 2024 |
| 2Q23 | $116.275 | −$6.812 | 5 MCG | Sincalide injection | v1, posted February 23, 2024 |
| 1Q23 | $123.087 | −$0.075 | 5 MCG | Sincalide injection | v1, posted December 6, 2023 |
| 4Q22 | $123.162 | +$3.895 | 5 MCG | Sincalide injection | v1, posted June 22, 2023 |
| 3Q22 | $119.267 | +$0.183 | 5 MCG | Sincalide injection | v1, posted June 9, 2023 |
| 2Q22 | $119.084 | +$3.436 | 5 MCG | Sincalide injection | v1, posted December 14, 2022 |
| 1Q22 | $115.648 | −$5.436 | 5 MCG | Sincalide injection | v1, posted June 8, 2022 |
| 4Q21 | $121.084 | +$3.19 | 5 MCG | Sincalide injection | v1, posted June 2, 2022 |
| 3Q21 | $117.894 | +$2.733 | 5 MCG | Sincalide injection | v1, posted June 2, 2022 |
| 2Q21 | $115.161 | −$0.391 | 5 MCG | Sincalide injection | v1, posted March 1, 2022 |
| 1Q21 | $115.552 | – | 5 MCG | Sincalide injection | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.